My Size warned on Nasdaq $1 bid price rule

My Size, Inc. received a notice from Nasdaq that its stock no longer meets the minimum bid price requirement of $1.00 per share for continued listing on the Nasdaq Capital Market.

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)

Form Type

8-K

Rhea-AI Filing Summary

My Size, Inc. received a notice from Nasdaq that its stock no longer meets the minimum bid price requirement of $1.00 per share for continued listing on the Nasdaq Capital Market. This follows 30 consecutive business days with a closing bid price below that level.

The company has 180 calendar days, until August 31, 2026, to regain compliance by achieving a closing bid of at least $1.00 for 10 consecutive business days. If it still does not comply, it may qualify for an additional 180-day period if it meets other Nasdaq listing standards.

If compliance is not regained, Nasdaq may move to delist the shares, though My Size would have the right to appeal. The company plans to monitor its share price and is considering options such as a potential reverse stock split to restore compliance.

Positive

None.

Negative

Nasdaq minimum bid price deficiency formally identified after 30 consecutive business days below $1.00, creating a structured path that can culminate in delisting if unresolved.
Finite compliance window with a 180-day period to restore the bid price, and only a potential second 180-day extension if other listing standards are met, heightening listing uncertainty.

Insights

Nasdaq bid-price deficiency raises clear delisting risk if unresolved.

My Size, Inc. has been notified that its shares failed Nasdaq’s $1.00 minimum bid requirement for 30 consecutive business days, triggering a formal deficiency period that can ultimately lead to delisting from the Nasdaq Capital Market.

The company has until August 31, 2026 to achieve a closing bid of at least $1.00 for 10 straight business days, with the possibility of a second 180-day extension if it satisfies other initial listing standards. Otherwise, Nasdaq may initiate delisting, subject to appeal to a Hearings Panel.

Management explicitly notes it may consider a reverse stock split to regain compliance. Such corporate actions can affect share count and trading dynamics, so subsequent disclosures around any proposed split or Nasdaq’s follow-up determinations will be key markers of how this listing issue evolves.

8-K Event Classification

Item 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

1 item

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Securities

The company received a delisting notice, failed to satisfy a continued-listing rule or standard, or transferred its listing.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did My Size, Inc. (MYSZ) disclose about its Nasdaq listing status?

My Size, Inc. disclosed that Nasdaq notified the company it no longer meets the minimum bid price requirement of $1.00 per share for listing on the Nasdaq Capital Market. This deficiency arose after 30 consecutive business days with a closing bid below that threshold.

How long does My Size, Inc. (MYSZ) have to regain Nasdaq bid price compliance?

My Size, Inc. has 180 calendar days, until August 31, 2026, to regain compliance. To do so, its common stock must achieve a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days during this period.

What happens if My Size, Inc. (MYSZ) cannot meet the Nasdaq bid price rule by August 31, 2026?

If My Size, Inc. does not regain compliance by August 31, 2026, it may qualify for an additional 180 days if it meets other Nasdaq Capital Market initial listing standards, excluding bid price, and notifies Nasdaq of its plan to cure the deficiency in that second period.

Could My Size, Inc. (MYSZ) be delisted from Nasdaq due to this notice?

Yes. If My Size, Inc. fails to regain compliance during the available cure periods, Nasdaq may determine to delist its common stock from the Nasdaq Capital Market. The company would then have an opportunity to appeal any delisting determination to a Nasdaq Hearings Panel.

Is My Size, Inc. (MYSZ) considering a reverse stock split to regain compliance?

My Size, Inc. stated it intends to monitor its closing bid price and may consider available options, including implementing a reverse stock split of its outstanding securities, as a way to regain compliance with Nasdaq’s $1.00 minimum bid price requirement.

Does the Nasdaq notice immediately affect trading of My Size, Inc. (MYSZ) stock?

The Nasdaq notice has no immediate effect on trading. My Size, Inc.’s common stock will continue to trade on the Nasdaq Capital Market under the symbol “MYSZ” while the company works through the 180-day compliance period and any potential extension or appeal process.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 03/02/2026 - 04:15 PM

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 2, 2026

MY SIZE, INC.

(Exact name of registrant as specified in its charter)

Delaware

001-37370

51-0394637

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

HaNegev 4, POB 1026,

Airport City, Israel 7010000

(Address of principal executive offices and Zip Code)

Registrant’s telephone number, including area code +972-3-600-9030

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.001 par value per share		MYSZ		Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

On March 2, 2026, My Size, Inc. (the “Company”) was notified (the “Notification Letter”) by the Nasdaq Listing Qualifications (“Nasdaq”) that it is not in compliance with the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of $1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of 30 consecutive business days. Based on the closing bid price of the Company’s common stock for the 30 consecutive business days prior to the date of the Notification Letter, the Company no longer meets the minimum bid price requirement. The Notification Letter has no immediate effect on the listing or trading of the Company’s common stock on the Nasdaq Capital Market and, at this time, the common stock will continue to trade on the Nasdaq Capital Market under the symbol “MYSZ”.

The Notification Letter provides that the Company has 180 calendar days, or until August 31, 2026, to regain compliance with Nasdaq Listing Rule 5550(a)(2). To regain compliance, the bid price of the Company’s common stock must have a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days. In the event the Company does not regain compliance by August 31, 2026, the Company may then be eligible for additional 180 days if it meets the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the bid price requirement, and will need to provide written notice of its intention to cure the deficiency during the second compliance period. If the Company does not qualify for the second compliance period or fails to regain compliance during the second compliance period, then Nasdaq will notify the Company of its determination to delist the Company’s common stock, at which point the Company will have an opportunity to appeal the delisting determination to a Hearings Panel.

The Company intends to monitor the closing bid price of its common stock and may, if appropriate, consider implementing available options, including, but not limited to, implementing a reverse stock split of its outstanding securities, to regain compliance with the minimum bid price requirement under the Nasdaq Listing Rules.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	MY SIZE, INC.

Date: March 2, 2026	By:	/s/ Ronen Luzon
	Name:	Ronen Luzon
	Title:	Chief Executive Officer

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

3 documents

My Size warned on Nasdaq $1 bid price rule